Oseltamivir Phosphate For Suspension
Product Images NDC 27241-139

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 27241-139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Oseltamivir Carton)

This is a description of a medication called Oseltamivir Phosphate Oral Suspension. It is a powder that is to be mixed into an oral suspension and is used to treat avian flu symptoms. The suspension can be stored for up to 17 days if refrigerated, or 10 days if kept at room temperature. The suspension must be shaken well before each use and discarded if not used after prescribed dosing. The package comes with a patient information insert and a child-resistant cap. The medication is marketed by Ajanta Pharma USA Inc. and made in India.*

FDA Label Image

Label (Oseltamivir Label)

This is a package insert for Oseltamivir Phosphate, an oral suspension used for the treatment of influenza. Each mL contains 6 mg of the active ingredient, oseltamivir. The suspension must be prepared at the time of dispensing by adding water, and the constituted product must be stored in the refrigerator and discarded after 17 days or kept at room temperature and discarded after 10 days. The package is child-resistant, and the usual dosage can be found in the package insert. The product is marketed by Ajanta Pharma USA Inc. and made in India.*

FDA Label Image

Oseltamivir Stru

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.